Global Age-related Macular Degeneration Market Size, Status and Forecast 2023-2027

Report ID: 1012416 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Wet AMD
        1.2.3 Dry AMD
    1.3 Market by Application
        1.3.1 Global Age-related Macular Degeneration Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Drugstore
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Age-related Macular Degeneration Market Perspective (2016-2027)
    2.2 Age-related Macular Degeneration Growth Trends by Regions
        2.2.1 Age-related Macular Degeneration Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Age-related Macular Degeneration Historic Market Share by Regions (2016-2021)
        2.2.3 Age-related Macular Degeneration Forecasted Market Size by Regions (2022-2027)
    2.3 Age-related Macular Degeneration Industry Dynamic
        2.3.1 Age-related Macular Degeneration Market Trends
        2.3.2 Age-related Macular Degeneration Market Drivers
        2.3.3 Age-related Macular Degeneration Market Challenges
        2.3.4 Age-related Macular Degeneration Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Age-related Macular Degeneration Players by Revenue
        3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2016-2021)
        3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2016-2021)
    3.2 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
    3.4 Global Age-related Macular Degeneration Market Concentration Ratio
        3.4.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2020
    3.5 Age-related Macular Degeneration Key Players Head office and Area Served
    3.6 Key Players Age-related Macular Degeneration Product Solution and Service
    3.7 Date of Enter into Age-related Macular Degeneration Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Age-related Macular Degeneration Breakdown Data by Type
    4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2016-2021)
    4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2022-2027)

5 Age-related Macular Degeneration Breakdown Data by Application
    5.1 Global Age-related Macular Degeneration Historic Market Size by Application (2016-2021)
    5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Age-related Macular Degeneration Market Size (2016-2027)
    6.2 North America Age-related Macular Degeneration Market Size by Type
        6.2.1 North America Age-related Macular Degeneration Market Size by Type (2016-2021)
        6.2.2 North America Age-related Macular Degeneration Market Size by Type (2022-2027)
        6.2.3 North America Age-related Macular Degeneration Market Size by Type (2016-2027)
    6.3 North America Age-related Macular Degeneration Market Size by Application
        6.3.1 North America Age-related Macular Degeneration Market Size by Application (2016-2021)
        6.3.2 North America Age-related Macular Degeneration Market Size by Application (2022-2027)
        6.3.3 North America Age-related Macular Degeneration Market Size by Application (2016-2027)
    6.4 North America Age-related Macular Degeneration Market Size by Country
        6.4.1 North America Age-related Macular Degeneration Market Size by Country (2016-2021)
        6.4.2 North America Age-related Macular Degeneration Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Age-related Macular Degeneration Market Size (2016-2027)
    7.2 Europe Age-related Macular Degeneration Market Size by Type
        7.2.1 Europe Age-related Macular Degeneration Market Size by Type (2016-2021)
        7.2.2 Europe Age-related Macular Degeneration Market Size by Type (2022-2027)
        7.2.3 Europe Age-related Macular Degeneration Market Size by Type (2016-2027)
    7.3 Europe Age-related Macular Degeneration Market Size by Application
        7.3.1 Europe Age-related Macular Degeneration Market Size by Application (2016-2021)
        7.3.2 Europe Age-related Macular Degeneration Market Size by Application (2022-2027)
        7.3.3 Europe Age-related Macular Degeneration Market Size by Application (2016-2027)
    7.4 Europe Age-related Macular Degeneration Market Size by Country
        7.4.1 Europe Age-related Macular Degeneration Market Size by Country (2016-2021)
        7.4.2 Europe Age-related Macular Degeneration Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Age-related Macular Degeneration Market Size (2016-2027)
    8.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type
        8.2.1 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2016-2027)
    8.3 Asia-Pacific Age-related Macular Degeneration Market Size by Application
        8.3.1 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2016-2027)
    8.4 Asia-Pacific Age-related Macular Degeneration Market Size by Region
        8.4.1 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Age-related Macular Degeneration Market Size (2016-2027)
    9.2 Latin America Age-related Macular Degeneration Market Size by Type
        9.2.1 Latin America Age-related Macular Degeneration Market Size by Type (2016-2021)
        9.2.2 Latin America Age-related Macular Degeneration Market Size by Type (2022-2027)
        9.2.3 Latin America Age-related Macular Degeneration Market Size by Type (2016-2027)
    9.3 Latin America Age-related Macular Degeneration Market Size by Application
        9.3.1 Latin America Age-related Macular Degeneration Market Size by Application (2016-2021)
        9.3.2 Latin America Age-related Macular Degeneration Market Size by Application (2022-2027)
        9.3.3 Latin America Age-related Macular Degeneration Market Size by Application (2016-2027)
    9.4 Latin America Age-related Macular Degeneration Market Size by Country
        9.4.1 Latin America Age-related Macular Degeneration Market Size by Country (2016-2021)
        9.4.2 Latin America Age-related Macular Degeneration Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Age-related Macular Degeneration Market Size (2016-2027)
    10.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type
        10.2.1 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2016-2027)
    10.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application
        10.3.1 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2016-2027)
    10.4 Middle East & Africa Age-related Macular Degeneration Market Size by Country
        10.4.1 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bayer HealthCare
        11.1.1 Bayer HealthCare Company Details
        11.1.2 Bayer HealthCare Business Overview
        11.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
        11.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.1.5 Bayer HealthCare Recent Development
    11.2 F. Hoffmann-La Roche
        11.2.1 F. Hoffmann-La Roche Company Details
        11.2.2 F. Hoffmann-La Roche Business Overview
        11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
        11.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.2.5 F. Hoffmann-La Roche Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Age-related Macular Degeneration Introduction
        11.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 Regeneron Pharmaceuticals
        11.4.1 Regeneron Pharmaceuticals Company Details
        11.4.2 Regeneron Pharmaceuticals Business Overview
        11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
        11.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.4.5 Regeneron Pharmaceuticals Recent Development
    11.5 Alcon
        11.5.1 Alcon Company Details
        11.5.2 Alcon Business Overview
        11.5.3 Alcon Age-related Macular Degeneration Introduction
        11.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.5.5 Alcon Recent Development
    11.6 Allergan
        11.6.1 Allergan Company Details
        11.6.2 Allergan Business Overview
        11.6.3 Allergan Age-related Macular Degeneration Introduction
        11.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.6.5 Allergan Recent Development
    11.7 Avalanche
        11.7.1 Avalanche Company Details
        11.7.2 Avalanche Business Overview
        11.7.3 Avalanche Age-related Macular Degeneration Introduction
        11.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.7.5 Avalanche Recent Development
    11.8 Bausch+Lomb
        11.8.1 Bausch+Lomb Company Details
        11.8.2 Bausch+Lomb Business Overview
        11.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
        11.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.8.5 Bausch+Lomb Recent Development
    11.9 Gilead Sciences
        11.9.1 Gilead Sciences Company Details
        11.9.2 Gilead Sciences Business Overview
        11.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
        11.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.9.5 Gilead Sciences Recent Development
    11.10 Iconic Therapeutics
        11.10.1 Iconic Therapeutics Company Details
        11.10.2 Iconic Therapeutics Business Overview
        11.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
        11.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.10.5 Iconic Therapeutics Recent Development
    11.11 Neurotech Pharmaceuticals
        11.11.1 Neurotech Pharmaceuticals Company Details
        11.11.2 Neurotech Pharmaceuticals Business Overview
        11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
        11.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.11.5 Neurotech Pharmaceuticals Recent Development
    11.12 Ohr Pharmaceutical
        11.12.1 Ohr Pharmaceutical Company Details
        11.12.2 Ohr Pharmaceutical Business Overview
        11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
        11.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2016-2021)
        11.12.5 Ohr Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Wet AMD
    Table 3. Key Players of Dry AMD
    Table 4. Global Age-related Macular Degeneration Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Age-related Macular Degeneration Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Age-related Macular Degeneration Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Age-related Macular Degeneration Market Share by Regions (2016-2021)
    Table 8. Global Age-related Macular Degeneration Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Age-related Macular Degeneration Market Share by Regions (2022-2027)
    Table 10. Age-related Macular Degeneration Market Trends
    Table 11. Age-related Macular Degeneration Market Drivers
    Table 12. Age-related Macular Degeneration Market Challenges
    Table 13. Age-related Macular Degeneration Market Restraints
    Table 14. Global Age-related Macular Degeneration Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Age-related Macular Degeneration Market Share by Players (2016-2021)
    Table 16. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-related Macular Degeneration as of 2020)
    Table 17. Ranking of Global Top Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Age-related Macular Degeneration Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Age-related Macular Degeneration Product Solution and Service
    Table 21. Date of Enter into Age-related Macular Degeneration Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Age-related Macular Degeneration Revenue Market Share by Type (2016-2021)
    Table 25. Global Age-related Macular Degeneration Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Age-related Macular Degeneration Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Age-related Macular Degeneration Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Age-related Macular Degeneration Revenue Market Share by Application (2016-2021)
    Table 29. Global Age-related Macular Degeneration Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Age-related Macular Degeneration Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Age-related Macular Degeneration Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Age-related Macular Degeneration Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Bayer HealthCare Company Details
    Table 62. Bayer HealthCare Business Overview
    Table 63. Bayer HealthCare Age-related Macular Degeneration Product
    Table 64. Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 65. Bayer HealthCare Recent Development
    Table 66. F. Hoffmann-La Roche Company Details
    Table 67. F. Hoffmann-La Roche Business Overview
    Table 68. F. Hoffmann-La Roche Age-related Macular Degeneration Product
    Table 69. F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 70. F. Hoffmann-La Roche Recent Development
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Age-related Macular Degeneration Product
    Table 74. Novartis Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 75. Novartis Recent Development
    Table 76. Regeneron Pharmaceuticals Company Details
    Table 77. Regeneron Pharmaceuticals Business Overview
    Table 78. Regeneron Pharmaceuticals Age-related Macular Degeneration Product
    Table 79. Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 80. Regeneron Pharmaceuticals Recent Development
    Table 81. Alcon Company Details
    Table 82. Alcon Business Overview
    Table 83. Alcon Age-related Macular Degeneration Product
    Table 84. Alcon Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 85. Alcon Recent Development
    Table 86. Allergan Company Details
    Table 87. Allergan Business Overview
    Table 88. Allergan Age-related Macular Degeneration Product
    Table 89. Allergan Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 90. Allergan Recent Development
    Table 91. Avalanche Company Details
    Table 92. Avalanche Business Overview
    Table 93. Avalanche Age-related Macular Degeneration Product
    Table 94. Avalanche Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 95. Avalanche Recent Development
    Table 96. Bausch+Lomb Company Details
    Table 97. Bausch+Lomb Business Overview
    Table 98. Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 99. Bausch+Lomb Recent Development
    Table 100. Gilead Sciences Company Details
    Table 101. Gilead Sciences Business Overview
    Table 102. Gilead Sciences Age-related Macular Degeneration Product
    Table 103. Gilead Sciences Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 104. Gilead Sciences Recent Development
    Table 105. Iconic Therapeutics Company Details
    Table 106. Iconic Therapeutics Business Overview
    Table 107. Iconic Therapeutics Age-related Macular Degeneration Product
    Table 108. Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 109. Iconic Therapeutics Recent Development
    Table 110. Neurotech Pharmaceuticals Company Details
    Table 111. Neurotech Pharmaceuticals Business Overview
    Table 112. Neurotech Pharmaceuticals Age-related Macular Degeneration Product
    Table 113. Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 114. Neurotech Pharmaceuticals Recent Development
    Table 115. Ohr Pharmaceutical Company Details
    Table 116. Ohr Pharmaceutical Business Overview
    Table 117. Ohr Pharmaceutical Age-related Macular Degeneration Product
    Table 118. Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
    Table 119. Ohr Pharmaceutical Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Age-related Macular Degeneration Market Share by Type: 2020 VS 2027
    Figure 2. Wet AMD Features
    Figure 3. Dry AMD Features
    Figure 4. Global Age-related Macular Degeneration Market Share by Application: 2020 VS 2027
    Figure 5. Drugstore Case Studies
    Figure 6. Hospital Case Studies
    Figure 7. Others Case Studies
    Figure 8. Age-related Macular Degeneration Report Years Considered
    Figure 9. Global Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Age-related Macular Degeneration Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Age-related Macular Degeneration Market Share by Regions: 2020 VS 2027
    Figure 12. Global Age-related Macular Degeneration Market Share by Regions (2022-2027)
    Figure 13. Global Age-related Macular Degeneration Market Share by Players in 2020
    Figure 14. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-related Macular Degeneration as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2020
    Figure 16. Global Age-related Macular Degeneration Revenue Market Share by Type (2016-2021)
    Figure 17. Global Age-related Macular Degeneration Revenue Market Share by Type (2022-2027)
    Figure 18. North America Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Age-related Macular Degeneration Market Share by Type (2016-2027)
    Figure 20. North America Age-related Macular Degeneration Market Share by Application (2016-2027)
    Figure 21. North America Age-related Macular Degeneration Market Share by Country (2016-2027)
    Figure 22. United States Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Age-related Macular Degeneration Market Share by Type (2016-2027)
    Figure 26. Europe Age-related Macular Degeneration Market Share by Application (2016-2027)
    Figure 27. Europe Age-related Macular Degeneration Market Share by Country (2016-2027)
    Figure 28. Germany Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Age-related Macular Degeneration Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Age-related Macular Degeneration Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Age-related Macular Degeneration Market Share by Region (2016-2027)
    Figure 38. China Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Age-related Macular Degeneration Market Share by Type (2016-2027)
    Figure 46. Latin America Age-related Macular Degeneration Market Share by Application (2016-2027)
    Figure 47. Latin America Age-related Macular Degeneration Market Share by Country (2016-2027)
    Figure 48. Mexico Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Age-related Macular Degeneration Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Age-related Macular Degeneration Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Age-related Macular Degeneration Market Share by Country (2016-2027)
    Figure 54. Turkey Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Bayer HealthCare Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 59. Novartis Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 61. Alcon Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 62. Allergan Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 63. Avalanche Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 64. Bausch+Lomb Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 65. Gilead Sciences Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 66. Iconic Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 67. Neurotech Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 68. Ohr Pharmaceutical Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Frequently Asked Questions
Age-related Macular Degeneration report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Age-related Macular Degeneration report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Age-related Macular Degeneration report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Text Analytics

Text analytics is the way to unlock the meaning from all of this unstructured text. It lets you u ... Read More